These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4127831)

  • 1. Rosette inhibition test for the demonstration of thymus-dependent lymphocyte sensitization in Graves's disease and Hashimoto's thyroiditis.
    Farid NR; Munro RE; Row VV; Volpé R
    N Engl J Med; 1973 Nov; 289(21):1111-7. PubMed ID: 4127831
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral thymus-dependent (T) lymphocytes in Graves's disease and Hashimoto's thyroiditis.
    Farid NR; Munro RE; Row VV; Volpé R
    N Engl J Med; 1973 Jun; 288(25):1313-7. PubMed ID: 4122370
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Proportion of E rosettes normal in Graves's and Hashimoto's disease: a retraction.
    Volpé R; Row VV
    N Engl J Med; 1975 Jul; 293(1):44. PubMed ID: 1079321
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of subgroups of euthyroid graves's ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith FJ
    N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of T-lymphocytes in Graves' and Hashimoto's diseases.
    Okita N; Kidd A; Row VV; Volpé R
    J Clin Endocrinol Metab; 1980 Aug; 51(2):316-20. PubMed ID: 6249836
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic aspects of Graves' and Hashimoto's diseases.
    Kidd A; Okita N; Row VV; Volpé R
    Metabolism; 1980 Jan; 29(1):80-99. PubMed ID: 6986013
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for thyroid antigen-reactive T lymphocytes infiltrating the thyroid gland in Graves' disease.
    Tötterman TH; Andersson LC; Häyry P
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):59-68. PubMed ID: 391444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of Graves' disease and Hashimoto's thyroiditis.
    Volpé R; Farid NR; Von Westarp C; Row VV
    Clin Endocrinol (Oxf); 1974 Jul; 3(3):239-61. PubMed ID: 4601273
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).
    Lamki L; Row VV; Volpé R
    J Clin Endocrinol Metab; 1973 Feb; 36(2):358-64. PubMed ID: 4739173
    [No Abstract]   [Full Text] [Related]  

  • 11. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-lymphocyte interaction in Graves' disease and Hashimoto's thyroiditis.
    Sugenoya A; Silverberg J; Trokoudes K; Row VV; Volpé R
    Acta Endocrinol (Copenh); 1979 May; 91(1):99-108. PubMed ID: 88154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of cell-mediated immunity (CMI) in relatives of patients with Grave's disease.
    Farid NR; Von Westarp C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1974 Oct; 39(4):779-84. PubMed ID: 4607110
    [No Abstract]   [Full Text] [Related]  

  • 14. Assays for antigen-stimulated lymphocyte-derived migration enhancement and inhibition factors from patients with thyroid diseases and their relatives.
    Matsui Y; Beall GN; Chopra IJ; Solomon DH; Kruger S; Beall M
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):733-41. PubMed ID: 335760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of stimulating, function-blocking and growth-blocking anti-TSH receptor antibodies (TRAbs) in GD, Hashimoto's disease and in atrophic thyroiditis.
    Orgiazzi J; Madec AM; Ducottet X
    Ann Endocrinol (Paris); 2003 Feb; 64(1):31-6. PubMed ID: 12707631
    [No Abstract]   [Full Text] [Related]  

  • 16. The pathogenesis of Graves' disease: an overview.
    Volpé R
    Clin Endocrinol Metab; 1978 Mar; 7(1):3-29. PubMed ID: 348355
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of antipituitary antibodies in patients with autoimmune thyroid disease.
    Nishino M; Yabe S; Murakami M; Kanda T; Kobayashi I
    Endocr J; 2001 Apr; 48(2):185-91. PubMed ID: 11456266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
    Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
    Wall JR; Chartier B
    J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis.
    Weetman AP; Volkman DJ; Burman KD; Margolick JB; Petrick P; Weintraub BD; Fauci AS
    Clin Immunol Immunopathol; 1986 Apr; 39(1):139-50. PubMed ID: 3485022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.